NCT06004011 is a NA clinical trial of ARROW strategies in Cervical Cancer, sponsored by Implenomics.

Who is sponsoring NCT06004011?

NCT06004011 is sponsored by Implenomics.

What drugs are being tested in NCT06004011?

Interventions in NCT06004011: ARROW strategies, One-time education.

What condition does NCT06004011 study?

NCT06004011 studies Cervical Cancer, Kaposi Sarcoma, Non Hodgkin Lymphoma.

Is NCT06004011 still recruiting?

NCT06004011 is currently recruiting now. Last updated 15 January 2026.

Last reviewed 2026-01-15 · How we verify

NCT06004011

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Recruiting now NA Last updated 15 January 2026

What this trial tests

NA trial testing ARROW strategies in Cervical Cancer in 4,100 participants. Currently enrolling.

Timeline

1 May 2024

Primary endpoint
31 August 2026

31 July 2027

Quick facts

Lead sponsor	Implenomics
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	4,100
Start date	1 May 2024
Primary completion	31 August 2026
Estimated completion	31 July 2027
Sites	1 location across Zambia

Drugs / interventions tested

ARROW strategies
One-time education

Conditions studied

Cervical Cancer — all drugs for Cervical Cancer →
Kaposi Sarcoma — all drugs for Kaposi Sarcoma →
Non Hodgkin Lymphoma — all drugs for Non Hodgkin Lymphoma →

Sponsor

Implenomics

Who can join

Adults 15 to 39, any sex, with Cervical Cancer or Kaposi Sarcoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers, interventions for early diagnosis and optimized treatment to reduce this cancer mortality are underutilized for this disproportionally impacted cohort. In this study, the investigators will test peer-to-peer education and support strategies to increase use of early diagnosis services in HIV treatment facilities and improve compliance with cancer treatment in the cancer center.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Viral oncogenesis in cancer: from mechanisms to therapeutics.
Xiao Q, Liu Y, Li T, Wang C, et al · · 2025 · cited 45× · PMID 40350456 · DOI 10.1038/s41392-025-02197-9
Integrated Model of Cancer Control for Early Detection and Treatment in Adolescents and Young Adults Living With HIV: Protocol for a Cluster Randomized Controlled Trial.
Batabyal S, Zirali P, Hoover S, Mungoni R, et al · · 2025 · PMID 40882199 · DOI 10.2196/68254

Verify or expand the search:

Other recruiting trials for Cervical Cancer

Currently open trials in the same condition.

NCT07276360 — Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda · Phase 2 · recruiting
NCT05570422 — A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01 · Phase 1 · recruiting
NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07209917 — Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India · NA · recruiting
NCT07256236 — SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer · Phase 2 · recruiting

Other Implenomics trials

Trials by the same sponsor.

NCT06572774 — Community Clinic Model to Improve Early Detection of Breast and Cervical Cancers in Kenya · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06004011 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Implenomics
Last refreshed: 15 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06004011.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing